Phase II Clinical Trial of Pegylated Liposomal Doxorubicin (JNS002) in Japanese Patients with Müllerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having a Therapeutic History of Platinum-based Chemotherapy: A Phase II Study of the Japanese Gynecologic Oncology Group

OBJECTIVE: This study was conducted to evaluate the efficacy and safety of pegylated liposomal doxorubicin (PLD) in Japanese patients with Müllerian carcinoma having a therapeutic history of platinum-based chemotherapy. METHODS: Patients who were diagnosed with Müllerian carcinoma (epithelial ovaria...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsumata, Noriyuki, Fujiwara, Yasuhiro, Kamura, Toshiharu, Nakanishi, Toru, Hatae, Masayuki, Aoki, Daisuke, Tanaka, Kenichi, Tsuda, Hiroshi, Kamiura, Shoji, Takehara, Kazuhiro, Sugiyama, Toru, Kigawa, Junzo, Fujiwara, Keiichi, Ochiai, Kazunori, Ishida, Ryo, Inagaki, Mitsuo, Noda, Kiichiro
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2008
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2572298/
https://www.ncbi.nlm.nih.gov/pubmed/18927230
http://dx.doi.org/10.1093/jjco/hyn101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2572298/
https://www.ncbi.nlm.nih.gov/pubmed/18927230
http://dx.doi.org/10.1093/jjco/hyn101

Ejemplares similares